{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.0","upperLimit":"27.0","value":"14.0"},{"groupId":"OG001","lowerLimit":"23.0","upperLimit":"23.0","value":"23.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"Specific features of CIPN assessed through the subscale from FACT-GOG-NTX will be determined for each subject as a composite measure, which is calculated as the sum of the responses to the subscale questions. For subjects who complete all 12 subscale questions, the composite score will range from 0 to 48. Higher scores mean worse outcome","dispersionType":"Full Range","groups":[{"description":"Acupuncture: 12 acupuncture sessions over 10 weeks","id":"OG000","title":"Acupuncture"},{"description":"Standard of Care CIPN management: Investigator directed standard of care management of CIPN","id":"OG001","title":"Standard of Care"}],"paramType":"MEDIAN","populationDescription":"The analysis population are those that met the evaluable population criteria, which was enrolled subjects who have complete baseline and Week 10 neuropathy scores.","reportingStatus":"POSTED","timeFrame":"10 weeks","title":"Specific Features of Chemotherapy-Induced Peripheral Neuropathy From FACT-GOG-NTX","type":"SECONDARY","unitOfMeasure":"Score on a scale"}